Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 130
Filter
1.
Int J Hematol ; 113(3): 348-361, 2021 Mar.
Article in English | MEDLINE | ID: mdl-33398631

ABSTRACT

Histidine decarboxylase (HDC), a histamine synthase, is expressed in various hematopoietic cells and is induced by hematopoietic cytokines such as granulocyte colony-stimulating factor (G-CSF). We previously showed that nitrogen-containing bisphosphonate (NBP)-treatment induces extramedullary hematopoiesis via G-CSF stimulation. However, the function of HDC in NBP-induced medullary and extramedullary hematopoiesis remains unclear. Here, we investigated changes in hematopoiesis in wild-type and HDC-deficient (HDC-KO) mice. NBP treatment did not induce anemia in wild-type or HDC-KO mice, but did produce a gradual increase in serum G-CSF levels in wild-type mice. NBP treatment also enhanced Hdc mRNA expression and erythropoiesis in the spleen and reduced erythropoiesis in bone marrow and the number of vascular adhesion molecule 1 (VCAM-1)-positive macrophages in wild-type mice, as well as increased the levels of hematopoietic progenitor cells and proliferating cells in the spleen and enhanced expression of bone morphogenetic protein 4 (Bmp4), CXC chemokine ligand 12 (Cxcl12), and hypoxia inducible factor 1 (Hif1) in the spleen. However, such changes were not observed in HDC-KO mice. These results suggest that histamine may affect hematopoietic microenvironments of the bone marrow and spleen by changing hematopoiesis-related factors in NBP-induced extramedullary hematopoiesis.


Subject(s)
Alendronate/antagonists & inhibitors , Bone Marrow/drug effects , Cellular Microenvironment/drug effects , Hematopoiesis, Extramedullary/drug effects , Histidine Decarboxylase/deficiency , Spleen/drug effects , Alendronate/pharmacology , Alendronate/toxicity , Anemia/chemically induced , Animals , Bone Marrow/metabolism , Bone Morphogenetic Protein 4/biosynthesis , Bone Morphogenetic Protein 4/genetics , Chemokine CXCL12/biosynthesis , Chemokine CXCL12/genetics , Enzyme Induction/drug effects , Erythroid Cells/pathology , Flow Cytometry , Granulocyte Colony-Stimulating Factor/blood , Histamine/biosynthesis , Histidine Decarboxylase/biosynthesis , Histidine Decarboxylase/genetics , Histidine Decarboxylase/physiology , Hypoxia-Inducible Factor 1, alpha Subunit/biosynthesis , Hypoxia-Inducible Factor 1, alpha Subunit/genetics , Macrophages/pathology , Mice , Mice, Inbred C57BL , Mice, Knockout , RNA, Messenger/biosynthesis , RNA, Messenger/genetics , Spleen/metabolism
2.
Alcohol ; 76: 47-57, 2019 05.
Article in English | MEDLINE | ID: mdl-30557779

ABSTRACT

We have reported that moderate prenatal alcohol exposure (PAE) elevates histamine H3 receptor-mediated inhibition of glutamatergic neurotransmission in dentate gyrus (DG), and that the H3 receptor antagonist ABT-239 ameliorates PAE-induced deficits in DG long-term potentiation. Here, we investigated whether PAE alters other markers of histaminergic neurotransmission. Long-Evans rat dams voluntarily consumed either a 0% or a 5% ethanol solution 4 h each day throughout gestation. Young adult female offspring from each prenatal treatment group were used in histidine decarboxylase (HDC) immunohistochemical studies of histamine neuron number in ventral hypothalamus, quantitative Western blotting studies of HDC expression in multiple brain regions, radiohistochemical studies of H2 receptor density in multiple brain regions, and in biochemical studies of H2 receptor-effector coupling in dentate gyrus. Rat dams consumed a mean of 1.90 g of ethanol/kg/day during pregnancy. This level of consumption did not affect maternal weight gain, offspring birth weight, or litter size. PAE did not affect the number of HDC-positive neurons in ventral hypothalamus. However, HDC expression was reduced in frontal cortex, dentate gyrus, and cerebellum of PAE rats compared to controls. Specific [125I]-iodoaminopotentidine binding to H2 receptors was not altered in any of the brain regions measured, nor was basal or H2 receptor agonist-stimulated cAMP accumulation in DG altered in PAE rats compared to controls. These results suggest that not all markers of histaminergic neurotransmission are altered by PAE. However, the observation that HDC levels were reduced in the same brain regions where elevated H3 receptor-effector coupling was observed previously raises the question of whether a cause-effect relationship exists between HDC expression and H3 receptor function in affected brain regions of PAE rats. This relationship, along with the question of why these effects occur in some, but not all brain regions, requires more-detailed investigation.


Subject(s)
Cerebellum/metabolism , Dentate Gyrus/metabolism , Frontal Lobe/metabolism , Histamine/metabolism , Histidine Decarboxylase/biosynthesis , Prenatal Exposure Delayed Effects/metabolism , Receptors, Histamine H2/metabolism , Animals , Cell Count , Female , Hypothalamus/drug effects , Male , Neurons/drug effects , Pregnancy , Radioligand Assay , Rats
3.
Br J Clin Pharmacol ; 83(3): 466-475, 2017 03.
Article in English | MEDLINE | ID: mdl-27704617

ABSTRACT

AIMS: Netazepide, a gastrin/cholecystokinin 2 receptor antagonist, once daily for 12 weeks reduced the number of tumours and size of the largest one in 16 patients with autoimmune chronic atrophic gastritis (CAG), achlorhydria, hypergastrinaemia and multiple gastric neuroendocrine tumours (type 1 gastric NETs), and normalized circulating chromogranin A (CgA) produced by enterochromaffin-like cells, the source of the tumours. The aim was to assess whether longer-term netazepide treatment can eradicate type 1 gastric NETs. METHODS: After a mean 14 months off netazepide, 13 of the 16 patients took it for another 52 weeks. Assessments were: gastroscopy; gene-transcript expression in corpus biopsies using quantitative polymerase chain reaction; blood CgA and gastrin concentrations; and safety assessments. RESULTS: While off-treatment, the number of tumours, the size of the largest one, and CgA all increased again. Netazepide for 52 weeks: cleared all tumours in 5 patients; cleared all but one tumour in one patient; reduced the number of tumours and size of the largest one in the other patients; normalized CgA in all patients; and reduced mRNA abundances of CgA and histidine decarboxylase in biopsies. Gastrin did not increase further, confirming that the patients had achlorhydria. Netazepide was safe and well tolerated. CONCLUSIONS: A gastrin/cholecystokinin 2 receptor antagonist is a potential medical and targeted treatment for type 1 gastric NETs, and an alternative to regular gastroscopy or surgery. Treatment should be continuous because the tumours will regrow if it is stopped. Progress can be monitored by CgA in blood or biomarkers in mucosal biopsies.


Subject(s)
Autoimmune Diseases/drug therapy , Benzodiazepinones/therapeutic use , Gastritis, Atrophic/drug therapy , Neuroendocrine Tumors/drug therapy , Phenylurea Compounds/therapeutic use , Achlorhydria/complications , Achlorhydria/drug therapy , Achlorhydria/metabolism , Aged , Autoimmune Diseases/blood , Autoimmune Diseases/complications , Benzodiazepinones/adverse effects , Chromogranin A/biosynthesis , Chromogranin A/blood , Gastrins/blood , Gastritis, Atrophic/blood , Gastritis, Atrophic/complications , Histidine Decarboxylase/biosynthesis , Humans , Middle Aged , Neuroendocrine Tumors/blood , Neuroendocrine Tumors/complications , Neuroendocrine Tumors/metabolism , Phenylurea Compounds/adverse effects
4.
PLoS One ; 11(12): e0152252, 2016.
Article in English | MEDLINE | ID: mdl-27997552

ABSTRACT

A competition of neurobehavioral drives of sleep and wakefulness occurs during sleep deprivation. When enforced chronically, subjects must remain awake. This study examines histaminergic neurons of the tuberomammillary nucleus of the posterior hypothalamus in response to enforced wakefulness in rats. We tested the hypothesis that the rate-limiting enzyme for histamine biosynthesis, L-histidine decarboxylase (HDC), would be up-regulated during chronic rapid eye movement sleep deprivation (REM-SD) because histamine plays a major role in maintaining wakefulness. Archived brain tissues of male Sprague Dawley rats from a previous study were used. Rats had been subjected to REM-SD by the flowerpot paradigm for 5, 10, or 15 days. For immunocytochemistry, rats were transcardially perfused with acrolein-paraformaldehyde for immunodetection of L-HDC; separate controls used carbodiimide-paraformaldehyde for immunodetection of histamine. Immunolocalization of histamine within the tuberomammillary nucleus was validated using carbodiimide. Because HDC antiserum has cross-reactivity with other decarboxylases at high antibody concentrations, titrations localized L-HDC to only tuberomammillary nucleus at a dilution of ≥ 1:300,000. REM-SD increased immunoreactive HDC by day 5 and it remained elevated in both dorsal and ventral aspects of the tuberomammillary complex. Our results suggest that up-regulation of L-HDC within the tuberomammillary complex during chronic REM-SD may be responsible for maintaining wakefulness.


Subject(s)
Histamine/metabolism , Histidine Decarboxylase/biosynthesis , Hypothalamic Area, Lateral/enzymology , Sleep Deprivation/enzymology , Up-Regulation , Wakefulness , Animals , Gene Expression Regulation, Enzymologic , Hypothalamic Area, Lateral/pathology , Male , Rats , Rats, Sprague-Dawley , Sleep Deprivation/pathology
5.
Biomed Res Int ; 2016: 2048987, 2016.
Article in English | MEDLINE | ID: mdl-27843938

ABSTRACT

Mast cells play an important role in the pathogenesis of allergic diseases. Immature mast cells migrate into peripheral tissues from the bone marrow and undergo complete maturation. Interestingly, mast cells have characteristics similar to hematopoietic stem cells (HSCs), such as self-renewal and c-kit expression. In HSCs, Wnt signaling is involved in their maintenance and differentiation. On the other hand, the relation between Wnt signaling and mast cell differentiation is poorly understood. To study whether Wnt signals play a role in the maturation of mast cells, we studied the effect of Wnt proteins on mast cell maturation of bone marrow-derived mast cells (BMMCs). The expression levels of CD81 protein and histidine decarboxylase mRNA and activity of mast cell-specific protease were all elevated in BMMCs treated with Wnt5a. In addition, Wnt5a induced the expression of Axin2 and TCF mRNA in BMMCs. These results showed that Wnt5a could promote the maturation of mast cells via the canonical Wnt signaling pathway and provide important insights into the molecular mechanisms underlying the differentiation of mast cells.


Subject(s)
Cell Differentiation/genetics , Hypersensitivity/genetics , Mast Cells/metabolism , Wnt-5a Protein/genetics , Animals , Axin Protein/biosynthesis , Bone Marrow Cells/metabolism , Gene Expression Regulation, Developmental , Histidine Decarboxylase/biosynthesis , Hypersensitivity/pathology , Mast Cells/cytology , Mice , Tetraspanin 28/biosynthesis , Wnt Signaling Pathway/genetics , Wnt-5a Protein/administration & dosage , Wnt-5a Protein/metabolism
6.
Acta Derm Venereol ; 94(6): 645-50, 2014 Nov.
Article in English | MEDLINE | ID: mdl-24603881

ABSTRACT

Shampoo and cleansers containing anionic surfactants including sodium dodecyl sulphate (SDS) often cause pruritus in humans. Daily application of 1-10% SDS for 4 days induced hind-paw scratching (an itch-related behaviour) in a concentration-dependent manner, and 10% SDS also caused dermatitis, skin dryness, barrier disruption, and an increase in skin surface pH in mice. SDS-induced scratching was inhibited by the opioid receptor antagonist naloxone and the H histamine receptor antagonist terfenadine. Mast-cell deficiency did not inhibit SDS-induced scratching, although it almost completely depleted histamine in the dermis. Treatment with SDS increased the histamine content of the epidermis, but not that of the dermis. SDS treatment increased the gene expression and post-translation processing of L-histidine decarboxylase in the epidermis. The present results suggest that repeated application of SDS induces itch through increased production of epidermal histamine, which results from an increase in the gene expression and post-translation processing of L-histidine decarboxylase.


Subject(s)
Epidermis/enzymology , Histamine/metabolism , Histidine Decarboxylase/biosynthesis , Mast Cells/enzymology , Pruritus/enzymology , Sarcosine/analogs & derivatives , Sodium Dodecyl Sulfate , Surface-Active Agents , Animals , Behavior, Animal/drug effects , Disease Models, Animal , Enzyme Induction , Histamine H1 Antagonists/pharmacology , Histidine Decarboxylase/genetics , Male , Mice, Inbred ICR , Narcotic Antagonists/pharmacology , Protein Processing, Post-Translational , Pruritus/chemically induced , Pruritus/genetics , Pruritus/prevention & control , Pruritus/psychology , Signal Transduction , Time Factors , Up-Regulation
7.
Curr Microbiol ; 68(3): 404-11, 2014 Mar.
Article in English | MEDLINE | ID: mdl-24241330

ABSTRACT

The histidine decarboxylase gene cluster of Morganella morganii DSM30146(T) was sequenced, and four open reading frames, named hdcT1, hdc, hdcT2, and hisRS were identified. Two putative histidine/histamine antiporters (hdcT1 and hdcT2) were located upstream and downstream the hdc gene, codifying a pyridoxal-P dependent histidine decarboxylase, and followed by hisRS gene encoding a histidyl-tRNA synthetase. This organization was comparable with the gene cluster of other known Gram negative bacteria, particularly with that of Klebsiella oxytoca. Recombinant Escherichia coli strains harboring plasmids carrying the M. morganii hdc gene were shown to overproduce histidine decarboxylase, after IPTG induction at 37 °C for 4 h. Quantitative RT-PCR experiments revealed the hdc and hisRS genes were highly induced under acidic and histidine-rich conditions. This work represents the first description and identification of the hdc-related genes in M. morganii. Results support the hypothesis that the histidine decarboxylation reaction in this prolific histamine producing species may play a role in acid survival. The knowledge of the role and the regulation of genes involved in histidine decarboxylation should improve the design of rational strategies to avoid toxic histamine production in foods.


Subject(s)
Gene Expression Profiling , Histidine Decarboxylase/biosynthesis , Histidine Decarboxylase/genetics , Morganella morganii/enzymology , Morganella morganii/genetics , Multigene Family , Cloning, Molecular , Escherichia coli/genetics , Gene Expression , Gene Order , Klebsiella oxytoca/genetics , Molecular Sequence Data , Open Reading Frames , Plasmids , Recombinant Proteins/genetics , Sequence Analysis, DNA , Synteny
8.
Front Neural Circuits ; 7: 102, 2013.
Article in English | MEDLINE | ID: mdl-23754986

ABSTRACT

Earlier studies in zebrafish have revealed that acutely given ethanol has a stimulatory effect on locomotion in fish larvae but the mechanism of this effect has not been revealed. We studied the effects of ethanol concentrations between 0.75 and 3.00% on 7-day-old larval zebrafish (Danio rerio) of the Turku strain. At 0.75-3% concentrations ethanol increased swimming speed during the first minute. At 3% the swimming speed decreased rapidly after the first minute, whereas at 0.75 and 1.5% a prolonged increase in swimming speed was seen. At the highest ethanol concentration dopamine levels decreased significantly after a 10-min treatment. We found that ethanol upregulates key genes involved in the biosynthesis of histamine (hdc) and dopamine (th1 and th2) following a short 10-min ethanol treatment, measured by qPCR. Using in situ hybridization and immunohistochemistry, we further discovered that the morphology of the histaminergic and dopaminergic neurons and networks in the larval zebrafish brain was unaffected by both the 10-min and a longer 30-min treatment. The results suggest that acute ethanol rapidly decreases dopamine levels, and activates both forms or th to replenish the dopamine stores within 30 min. The dynamic changes in histaminergic and dopaminergic system enzymes occurred in the same cells which normally express the transcripts. As both dopamine and histamine are known to be involved in the behavioral effects of ethanol and locomotor stimulation, these results suggest that rapid adaptations of these networks are associated with altered locomotor activity.


Subject(s)
Ethanol/administration & dosage , Histidine Decarboxylase/biosynthesis , Nerve Net/drug effects , Nerve Net/enzymology , Tyrosine 3-Monooxygenase/biosynthesis , Up-Regulation/drug effects , Zebrafish Proteins/biosynthesis , Animals , Brain/drug effects , Brain/enzymology , Larva , Motor Activity/drug effects , Motor Activity/physiology , Up-Regulation/physiology , Zebrafish
9.
Eur J Gastroenterol Hepatol ; 25(4): 474-81, 2013 Apr.
Article in English | MEDLINE | ID: mdl-23249603

ABSTRACT

BACKGROUND: Type-1 gastric neuroendocrine tumours (NETs) arise in some patients with chronic hypergastrinaemia secondary to autoimmune atrophic gastritis. Patients with small tumours are usually managed conservatively, because their prognosis is very good. However, larger tumours may require surgical intervention. Many type-1 gastric NETs regress following antrectomy because this removes the source of hypergastrinaemia. However, some tumours do not regress following antrectomy and additional surgery may be required. An octreotide suppression test has been previously suggested as a means to assess whether type-1 gastric NETs are likely to regress following antrectomy. AIM: To prospectively examine the role of a short-term intravenous octreotide suppression test in predicting type-1 gastric NET regression in five patients who subsequently underwent antrectomy. MATERIALS AND METHODS: Serum gastrin concentrations and gastric corpus and tumour histidine decarboxylase mRNA abundances were assessed in patients with type-1 gastric NETs before and 72 h after the administration of 25 µg/h intravenous octreotide. Gastric tumour response was assessed endoscopically following subsequent antrectomy. RESULTS: All patients showed significant decreases in serum gastrin concentrations as well as corpus and tumour biopsy histidine decarboxylase mRNA abundance following octreotide infusion. All patients also showed resolution of hypergastrinaemia following subsequent antrectomy. However, tumour regression was only observed in four of the five patients. One patient had a persistent tumour 3 years after antrectomy and required additional surgical resection. CONCLUSION: A positive octreotide suppression test result does not always predict response to antrectomy in patients with type-1 gastric NETs. Assessment of gastric mucosal responses to a gastrin/CCK-2 receptor antagonist may therefore also be helpful.


Subject(s)
Antineoplastic Agents, Hormonal , Neuroendocrine Tumors/diagnosis , Octreotide , Pyloric Antrum/surgery , Stomach Neoplasms/diagnosis , Adult , Aged , Antineoplastic Agents, Hormonal/administration & dosage , Female , Gastrectomy/methods , Gastrins/blood , Gastroscopy/methods , Histidine Decarboxylase/biosynthesis , Histidine Decarboxylase/genetics , Humans , Infusions, Intravenous , Male , Neuroendocrine Tumors/surgery , Octreotide/administration & dosage , Patient Selection , Prognosis , Prospective Studies , RNA, Messenger/genetics , Stomach Neoplasms/surgery , Treatment Outcome
10.
Biol Reprod ; 87(6): 150, 2012 Jun.
Article in English | MEDLINE | ID: mdl-23077168

ABSTRACT

Mast cells (MC) occur normally in the testis with a species-specific distribution, yet their precise role remains unclear. Testicular MC express histidine decarboxylase (HDC), the unique enzyme responsible for histamine (HA) generation. Evidence to date supports a role for HA as a local regulator of steroidogenesis via functional H1 and H2 receptor subtypes (HRH1 and HRH2, respectively) present in Leydig cells. Given that HA is a well-known modulator of physiological and pathological proliferation in many different cell types, we aimed in the present study to evaluate whether HA might contribute to the regulation of Leydig cell number as well as to the control of androgen production. Herein, we demonstrate, to our knowledge for the first time, that MA-10 Leydig tumor cells, but not normal immature Leydig cells (ILC), exhibit a proliferative response upon stimulation with HA that involves HRH2 activation, transient elevation of cAMP levels, and increased extracellular signal-regulated kinase (ERK) phosphorylation. Our results also reveal that MA-10 cells show significantly heightened HDC expression compared to normal ILC or whole-testicular lysate and that inhibition of HDC activity decreases MA-10 cell proliferation, suggesting a possible correlation between autocrine overproduction of HA and abnormally increased proliferation in Leydig cells. The facts that germ cells are also both source and target of HA and that multiple testicular cells are susceptible to HA action underline the importance of the present study, which we hope will serve as a first step for further research into regulation of non-MC-related HDC expression within the testis and its significance for testicular function.


Subject(s)
Cyclic AMP/metabolism , Extracellular Signal-Regulated MAP Kinases/metabolism , Histamine/metabolism , Leydig Cell Tumor/metabolism , Leydig Cells/metabolism , Receptors, Histamine H2/metabolism , Second Messenger Systems , Animals , Cell Line, Tumor , Cell Proliferation/drug effects , Cells, Cultured , Cyclic AMP/antagonists & inhibitors , Enzyme Inhibitors/pharmacology , Extracellular Signal-Regulated MAP Kinases/antagonists & inhibitors , Histamine Agonists/metabolism , Histamine Agonists/pharmacology , Histidine Decarboxylase/antagonists & inhibitors , Histidine Decarboxylase/biosynthesis , Histidine Decarboxylase/metabolism , Leydig Cell Tumor/drug therapy , Leydig Cell Tumor/enzymology , Leydig Cells/cytology , Leydig Cells/drug effects , Leydig Cells/enzymology , Male , Mice , Neoplasm Proteins/antagonists & inhibitors , Neoplasm Proteins/biosynthesis , Neoplasm Proteins/metabolism , Phosphorylation/drug effects , Protein Processing, Post-Translational/drug effects , Rats , Rats, Sprague-Dawley , Receptors, Histamine H2/chemistry , Second Messenger Systems/drug effects , Stem Cells/cytology , Stem Cells/drug effects , Stem Cells/metabolism
11.
J Dermatol Sci ; 67(2): 95-100, 2012 Aug.
Article in English | MEDLINE | ID: mdl-22726259

ABSTRACT

BACKGROUND: With the introduction of hair regeneration techniques using epidermal and dermal cells, hair follicle regeneration became much easier and faster. Current success has been dependent on the availability of cells from newborn or embryonic mice. We recently observed that the hair-inducing ability of newborn mouse dermal cells disappeared in the first few days of life and there was a drastic decrease of histidine decarboxylase (HDC) gene expression from postnatal day 0 (p0) to day 7 (p7). OBJECTIVE: The aim of this study was to study the role of HDC in hair follicle induction. METHODS: The mRNA levels of HDC in p0, p7 and p48 C57BL/6 mouse skin were checked with a real time reverse transcription polymerase chain reaction and immunohistochemistry. To test the effect of HDC, HDC expression in p0 mouse dermal cells was suppressed with small interfering RNA (siRNA) transfection. Mock treated and HDC siRNA treated cells were then injected with adult epidermal cells into nude mice skin. Three weeks later, the number, length and thickness of induced hairs were compared. RESULTS: Compared with p0, the mRNA level of HDC was much lower at p7 and p48. Immunohistochemical staining also revealed a marked decrease of HDC expression in p7 mice skin, compared with p0 skin. Hair patch assays showed that the HDC siRNA treated p0 dermal cells induced less hair follicle structures and shorter and thinner hair shafts than mock treated cells. CONCLUSION: HDC, whose expression is remarkably downregulated during the first few days after birth in dermal cells of mice, plays essential roles in the hair-inducing ability of newborn mouse dermal cells.


Subject(s)
Epidermis/enzymology , Gene Expression Regulation, Developmental , Gene Expression Regulation, Enzymologic , Histidine Decarboxylase/biosynthesis , Skin/metabolism , Animals , Animals, Newborn , Cell Culture Techniques , Female , Hair/metabolism , Hair Follicle/metabolism , Male , Mice , Mice, Inbred C57BL , Mice, Nude , RNA Interference , Time Factors
13.
Innate Immun ; 16(4): 265-72, 2010 Aug.
Article in English | MEDLINE | ID: mdl-19710098

ABSTRACT

We investigated the immunopharmacological aspects of innate immune responses via Toll-like receptors (TLRs), NOD1 and NOD2, in terms of induction of the histamine-forming enzyme, histidine decarboxylase (HDC), activity in mice. Intravenous injection of TLR4-agonistic synthetic lipid A definitely induced HDC activity in the liver, spleen, and lungs, especially the lungs, in mice, where maximum activity was induced about 3 h after the injection of lipid A. The TLR2/6 agonistic synthetic diacyl-type lipopeptide FSL-1 and TLR3-agonistic poly I:C were also effective in inducing HDC, while the NOD2-agonistic synthetic muramyldipeptide (MDP) and NOD1-agonistic synthetic FK156 and FK565 exhibited only weak activities in this respect. Mice primed with intravenous injection of NOD1 or NOD2 agonists produced higher HDC activity following the 4-6 h later intravenous challenge with the above TLR agonists. Among the priming agents, FK565 exhibited the strongest activity, and it was effective via various administration routes - intraperitoneal, subcutaneous, intramuscular, as well as intravenous injection; furthermore, oral (gastric) administration was effective, although it needed a dose 10 times higher than that required for other administration routes. These findings suggest that HDC is induced in association with TLRs and NOD1/2, and that the newly formed histamine by the induced HDC might play important roles in the regulation of inflammatory and immune responses in various organs.


Subject(s)
Histidine Decarboxylase/biosynthesis , Nod1 Signaling Adaptor Protein/pharmacology , Nod2 Signaling Adaptor Protein/pharmacology , Toll-Like Receptors/agonists , Acetylmuramyl-Alanyl-Isoglutamine/pharmacology , Animals , Diaminopimelic Acid/analogs & derivatives , Diaminopimelic Acid/pharmacology , Histamine/metabolism , Indicators and Reagents , Lipid A/pharmacology , Lung/drug effects , Lung/enzymology , Male , Mice , Mice, Inbred BALB C , Oligopeptides/pharmacology
14.
J Pharmacol Sci ; 109(4): 606-17, 2009 Apr.
Article in English | MEDLINE | ID: mdl-19352071

ABSTRACT

Kujin, the dried root of Sophorae flavescensis, has been used in Chinese folklore medicine against allergy. Evaluation of its anti-allergic potential as well as its mechanism of action has rarely been established. We investigated the effect of Kujin on toluene-2,4-diisocyanate (TDI)-induced allergic behavior and related histamine signaling including mRNA levels of histamine H(1) receptor (H1R) and histidine decarboxylase (HDC), H1R and HDC activities, and histamine content in rat nasal mucosa. We also investigated the effect of Kujin on the mRNA levels of helper T cell type 2 (Th2)-cytokine genes closely related to histamine signaling. TDI provocation caused acute allergic symptoms accompanied with up-regulations of H1R and HDC mRNAs and increases in HDC activity, histamine content, and [(3)H]mepyramine binding activity in the nasal mucosa, all of which were significantly suppressed by pretreatment with Kujin for 3 weeks. Kujin also suppressed the TDI-induced IL-4 and IL-5 mRNA elevations. These data suggest that oral administration of Kujin showed anti-allergic activity through suppression of histamine signaling by the inhibition of TDI-induced H1R and HDC mRNA elevations followed by decrease in H1R, HDC protein level, and histamine content in the nasal mucosa of TDI-sensitized rats. Suppression of Th2-cytokine signaling by Kujin also suggests that it could affect the histamine-cytokine network.


Subject(s)
Fabaceae/chemistry , Histamine Antagonists/pharmacology , Histamine/physiology , Hypersensitivity/drug therapy , Toluene 2,4-Diisocyanate/toxicity , Animals , Cytokines/drug effects , Cytokines/metabolism , Histamine H1 Antagonists/metabolism , Histamine Release/drug effects , Histidine Decarboxylase/biosynthesis , Male , Nasal Mucosa/drug effects , Nasal Mucosa/metabolism , Plant Roots/chemistry , Pyrilamine/metabolism , RNA, Messenger/biosynthesis , RNA, Messenger/genetics , Rats , Rats, Inbred BN , Receptors, Histamine H1/biosynthesis , Receptors, Histamine H1/genetics , Reverse Transcriptase Polymerase Chain Reaction , Signal Transduction/drug effects , Th2 Cells/drug effects , Th2 Cells/metabolism , Transcription, Genetic/drug effects
15.
Cell Mol Life Sci ; 65(10): 1585-95, 2008 May.
Article in English | MEDLINE | ID: mdl-18408884

ABSTRACT

Mast cell activation involves the rapid release of inflammatory mediators, including histamine, from intracellular granules. The cells are capable of regranulation and multiple rounds of activation. The goal of this study was to determine if there are changes in the content of pre-formed mast cell mediators after a round of activation. After 24 h, the histamine content of bone marrow-derived mast cells (BMMC), but not that of peritoneal mast cells, exceeded the amount in resting cells. Accumulation of histamine in BMMC peaked at 72 h of activation, and returned toward preactivation levels by 96 h. The increase in histamine content was accompanied by an increase in the gene expression of histidine decarboxylase. No increases in beta hexosaminidase or murine mast cell protease-6 were observed. These findings indicate that BMMC respond to activation by increasing total cell-associated histamine content. This increase may be important to the response of these cells upon subsequent exposure to antigens.


Subject(s)
Cell Differentiation , Histamine/metabolism , Mast Cells/metabolism , Mast Cells/physiology , Animals , Bone Marrow Cells/cytology , Bone Marrow Cells/physiology , Cell Count , Cell Differentiation/immunology , Cell Proliferation , Cytoplasmic Granules/metabolism , Enzyme Induction , Female , Histidine Decarboxylase/biosynthesis , Histidine Decarboxylase/genetics , Mast Cells/cytology , Mast Cells/immunology , Mice , Mice, Inbred C57BL , Peritoneal Cavity/cytology
16.
Neuroscience ; 152(1): 273-87, 2008 Mar 03.
Article in English | MEDLINE | ID: mdl-18082968

ABSTRACT

Infection and inflammation strongly inhibit a variety of behaviors, including exploration, social interaction, and food intake. The mechanisms that underlie sickness behavior remain elusive, but appear to involve fatigue and a state of hypo-arousal. Because histaminergic neurons in the ventral tuberomammillary nucleus of the hypothalamus (VTM) play a crucial role in the mediation of alertness and behavioral arousal, we investigated whether the histaminergic system represents a target for immune activation and, if so, whether modulation by ascending medullary immune-sensitive projections represents a possible mechanism. Rats were injected intraperitoneally with either the pro-inflammatory stimulus lipopolysaccharide (LPS) or saline, and exposed to one of various behavioral tests that would induce motivated behavior (exploration, play behavior, social interaction, sweetened milk consumption). Upon kill, brains were processed for c-Fos and histidine decarboxylase immunoreactivity. LPS treatment reduced behavioral activity and blocked behavioral test-associated c-Fos induction in histaminergic neurons of the VTM. These effects of LPS were prevented by prior inactivation of the caudal medullary dorsal vagal complex (DVC) with a local anesthetic. To determine whether LPS-responsive brainstem projection neurons might provide a link from the DVC to the VTM, the tracer Fluorogold was iontophoresed into the VTM a week prior to experiment. Retrogradely labeled neurons that expressed c-Fos in response to LPS treatment included catecholaminergic neurons within the nucleus of the solitary tract and ventrolateral medulla. These findings support the hypothesis that the histaminergic system represents an important component in the neurocircuitry relevant for sickness behavior that is linked to ascending pathways originating in the lower brainstem.


Subject(s)
Afferent Pathways/metabolism , Behavior, Animal/physiology , Brain/metabolism , Histamine/metabolism , Inflammation/physiopathology , Neuroimmunomodulation/physiology , Animals , Brain/drug effects , Brain/immunology , Histidine Decarboxylase/biosynthesis , Immunohistochemistry , Inflammation/chemically induced , Lipopolysaccharides/toxicity , Male , Neurons/metabolism , Proto-Oncogene Proteins c-fos/biosynthesis , Rats , Rats, Sprague-Dawley
17.
Appl Environ Microbiol ; 74(3): 811-7, 2008 Feb.
Article in English | MEDLINE | ID: mdl-18065614

ABSTRACT

Lactic acid bacteria contribute to wine transformation during malolactic fermentation. They generally improve the sensorial properties of wine, but some strains produce histamine, a toxic substance that causes health issues. Histamine-producing strains belong to species of the genera Oenococcus, Lactobacillus, and Pediococcus. All carry an hdcA gene coding for a histidine decarboxylase that converts histidine into histamine. For this study, a method based on quantitative PCR and targeting hdcA was developed to enumerate these bacteria in wine. This method was efficient for determining populations of 1 to 10(7) CFU per ml. An analysis of 264 samples collected from 116 wineries of the same region during malolactic fermentation revealed that these bacteria were present in almost all wines and at important levels, exceeding 10(3) CFU per ml in 70% of the samples. Histamine occurred at an often important level in wines containing populations of the above-mentioned bacteria. Fifty-four colonies of histamine producers isolated from four wines were characterized at the genetic level. All were strains of Oenococcus oeni that grouped into eight strain types by randomly amplified polymorphic DNA analysis. Some strains were isolated from wines collected in distant wineries. Moreover, hdcA was detected on a large and possibly unstable plasmid in these strains of O. oeni. Taken together, the results suggest that the risk of histamine production exists in almost all wines and is important when the population of histamine-producing bacteria exceeds 10(3) per ml. Strains of O. oeni producing histamine are frequent in wine during malolactic fermentation, but they may lose this capacity during subcultures in the laboratory.


Subject(s)
Gram-Positive Cocci/enzymology , Gram-Positive Cocci/isolation & purification , Histamine/biosynthesis , Histidine Decarboxylase/biosynthesis , Wine/microbiology , Bacterial Typing Techniques , Colony Count, Microbial , Fermentation , Gram-Positive Cocci/classification , Gram-Positive Cocci/genetics , Histidine Decarboxylase/genetics , Phenotype , Random Amplified Polymorphic DNA Technique
18.
APMIS ; 116(12): 1034-42, 2008 Dec.
Article in English | MEDLINE | ID: mdl-19133005

ABSTRACT

Histamine is produced by mast cells and many other types of cells. The role of histamine released from mast cells in promoting tumor angiogenesis has been intensively studied; however, the role of non-mast cell histamine in regulating tumor angiogenesis has been largely ignored. In this study, tissue specimen sections from 43 patients with esophageal squamous cell carcinoma (ESCC) and normal esophageal biopsies from 17 heath individuals obtained from a high incidence area of north China were used to assess changes in microvessel density (MVD) and non-mast cell L-histidine decarboxylase (HDC) (the only rate-limiting enzyme that catalyzes the formation of histamine from L-histidine) expression in the tumor microenvironment by immunohistochemistry (IHC). In addition, the cellular characterization of non-mast cell HDC-positive cells in microvessels was examined by double IHC combined with HDC/CD34 and HDC/PCNA antibodies. These IHC analyses revealed a significantly increased HDC-positive MVD in ESCC as compared with normal controls, which accounted for approximately 61% of CD34-labeled general MVD in ESCC. Furthermore, IHC in serial sections and double IHC showed that most of these HDC-positive cells were CD34-positive endothelial cells in microvessels with an increased proliferative capacity. Thus, our results suggest that non-mast cell histamine expressed in endothelial cells of microvessels could be an additional cellular source and might play a role in regulating angiogenesis in ESCC.


Subject(s)
Carcinoma, Squamous Cell/blood supply , Esophageal Neoplasms/blood supply , Histidine Decarboxylase/biosynthesis , Microvessels/enzymology , Neoplasm Proteins/biosynthesis , Neovascularization, Pathologic/enzymology , Antigens, CD34/analysis , Carcinoma, Squamous Cell/pathology , Endothelial Cells/enzymology , Esophageal Neoplasms/pathology , Esophagus/blood supply , Esophagus/pathology , Female , Histidine Decarboxylase/analysis , Humans , Immunohistochemistry , Male , Microvessels/growth & development , Middle Aged , Neoplasm Proteins/analysis , Proliferating Cell Nuclear Antigen/analysis
19.
Neuroimmunomodulation ; 14(2): 97-104, 2007.
Article in English | MEDLINE | ID: mdl-17713357

ABSTRACT

Activation of cytokine receptors and alterations in cytokines are thought to play important roles in neuronal dysfunction and in the pathogenesis of the nervous system diseases. CXCL8 (IL-8) is a CXC chemokine with chemotactic and inflammatory properties. Chemokines control mast cell infiltration in several inflammatory diseases, including stress and neurological dysfunctions. Using isolated human umbilical cord blood-derived cultured mast cells (HUCMC) from hematopoietic stem cells CD34+, mast cells were immunologically activated with anti-IgE at concentrations of 1, 5, 10 and 20 microg/ml leading to the dose-dependent production of IL-8 (p < 0.05). The increase in IL-8 mRNA expression was also noted when the cells were treated with anti-IgE at 10 microg/ml for 6 h. Immunologically activated HUCMC provoked the generation of tryptase in a dose- and time-dependent manner. We also found increased histidine decarboxylase (HDC) expression in activated HUCMC after 6 h of incubation, a rate-limiting enzyme responsible for the generation of histamine from histidine. Taken together, these results confirm that anti-IgE-activated mast cells release inflammatory mediators including CXCL8, a CXC chemokine which regulates several biological effects of mast cells, e.g. chemoattraction, and possibly causes cell arrest.


Subject(s)
Antibodies, Anti-Idiotypic/immunology , Histidine Decarboxylase/biosynthesis , Immunoglobulin E/immunology , Interleukin-8/metabolism , Mast Cells/immunology , Tryptases/metabolism , Cells, Cultured , Fetal Blood/cytology , Gene Expression/immunology , Histidine Decarboxylase/genetics , Humans , Microscopy, Electron, Transmission , RNA, Messenger , Reverse Transcriptase Polymerase Chain Reaction , Transcription, Genetic
20.
Int Arch Allergy Immunol ; 144(1): 69-78, 2007.
Article in English | MEDLINE | ID: mdl-17505141

ABSTRACT

BACKGROUND: Previous findings suggest that antigen challenge (AC) may induce histidine decarboxylase (HDC) in cells other than mast cells (MCs) via MC-derived IL-1. We examined this hypothesis. METHODS: Mice were sensitized to ovalbumin. After the sensitization, an AC was delivered intravenously. RESULTS: In control mice, AC markedly induced HDC at a postanaphylactic time in the liver, lung, spleen, and ears. In MC-deficient W/W(v) mice, AC also induced HDC, although the effect was weaker than in control mice. AC increased IL-1 in the tissues, the pattern being similar in W/W(v) and control mice. AC induced HDC similarly in IL-1-deficient and control mice. In control mice, AC decreased histamine in the tissues (except the liver) for several hours. CONCLUSION: (1) AC induces HDC in both MC-dependent and MC-independent ways. (2) AC induces IL-1 mostly in non-MCs, but this IL-1 is not a prerequisite for the induction of HDC by AC. (3) HDC induction may contribute to the replenishment of the reduced pool of MC histamine in the anaphylactic period. (4) In the case of MC-dependent HDC induction, AC may stimulate MCs in such a way as to induce HDC within the MCs themselves, and/or AC-stimulated MCs may stimulate HDC induction in other cells, which will need to be directly identified in future studies.


Subject(s)
Antigens/administration & dosage , Histidine Decarboxylase/biosynthesis , Interleukin-1/physiology , Mast Cells/enzymology , Mast Cells/immunology , Animals , Antigens/immunology , Chickens , Enzyme Activation/immunology , Enzyme Induction/immunology , Female , Histidine Decarboxylase/metabolism , Injections, Intraperitoneal , Injections, Intravenous , Interleukin-1/biosynthesis , Interleukin-1/deficiency , Interleukin-1/genetics , Mice , Mice, Inbred BALB C , Mice, Knockout , Organ Specificity/immunology , Ovalbumin/administration & dosage , Ovalbumin/immunology , Up-Regulation/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...